Unversity of Tübingen
160 papers found
The abl/bcr gene product as a novel leukemia-specific antigen: peptides spanning the fusion region of abl/bcr can be recognized by both CD4+ and CD8+ T lymphocytes.
Synthetic peptides derived from the Wilms' tumor 1 protein sensitize human T lymphocytes to recognize chronic myelogenous leukemia cells
T Cell Immunosenescence
Cancer vaccination progress
Immunogenicity of WT-1 peptides
Is human immunosenescence clinically relevant? Looking for ‘immunological risk phenotypes’
Prediction of an HLA-DR-binding peptide derived from Wilms’ tumour 1 protein and demonstration of in vitro immunogenicity of WT1(124–138)-pulsed dendritic cells generated according to an optimised protocol
Is human aging still mysterious enough to be left only to scientists?
T cells and aging, January 2002 update.
Escape mechanisms in tumor immunity: an update.
Mitochondrial DNA damage in lymphocytes: A role in immunosenescence?
Senescence: the cost of being young and healthy?
HER-2/neu-derived peptide 884-899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4 + T cell clones
Compromised interferon gamma (IFN-gamma) production in the elderly to both acute and latent viral antigen stimulation: contribution to the immune risk phenotype?
Human CD4+ T cell clone longevity in tissue culture: lack of influence of donor age or cell origin
Chronic Phase CML Patients Possess T Cells Capable of Recognising Autologous Tumour Cells
Basic biology and clinical impact of immunosenescence
Escape Mechanisms in Tumour Immunity
Immune Receptor Signaling, Aging and Autoimmunity
Human T-Cell Clones
Missing publications? Search for publications with a matching author name.